Systematic review of gouty arthritis models highlights limitations in reproducing human disease complexity.

A systematic review was conducted to assess the utility of various experimental models for studying gouty arthritis. The evaluation encompassed exogenous monosodium urate (MSU) models, hyperuricemia models, composite models, and in vitro systems. The review did not report a specific population, sample size, or clinical setting, as the focus was on the modeling systems themselves rather than a patient cohort. No comparator group or specific primary outcomes were detailed in the available data.

The main results of the review indicate that existing models possess significant gaps in mimicking human pathology. Specifically, these models fail to fully reproduce the complexity of human gout, particularly concerning metabolic initiation, tissue hierarchy, systemic context, and species-specific differences. Because these fundamental biological contexts are not adequately captured, the direct translation of results from these models to human clinical practice remains uncertain.

Safety and tolerability data were not reported, as the study focused on the fidelity of disease models rather than drug administration or adverse event monitoring. The review identified key limitations inherent to the current state of gout modeling, noting that species-specific differences and the lack of a complete systemic context hinder accurate representation of human disease. These limitations suggest that while these models offer some utility, they are insufficient for fully predicting human responses to interventions.

Given the inability of current models to replicate the full complexity of human gout, the practice relevance for guiding clinical decisions is constrained. Clinicians must recognize that results derived from these imperfect models should not be overinterpreted as definitive evidence for human treatment efficacy or safety. Future research must address the identified gaps in metabolic and systemic representation to improve model validity.